MARKET

CMMB

CMMB

Chemomab Therapeutics Ltd
NASDAQ

Real-time Quotes | Nasdaq Last Sale

27.26
-6.32
-18.82%
After Hours: 26.98 -0.28 -1.03% 17:59 04/16 EDT
OPEN
32.83
PREV CLOSE
33.58
HIGH
33.08
LOW
25.33
VOLUME
167.94K
TURNOVER
--
52 WEEK HIGH
168.80
52 WEEK LOW
12.00
MARKET CAP
291.63M
P/E (TTM)
-0.2722
1D
5D
1M
3M
1Y
5Y
Update: Chemomab Therapeutics Plummets 17.5% After Filing Shelf of Up to 7.2 Million ADSs on Behalf of Selling Shareholders
MT Newswires · 2d ago
Wall Street Holds on to Gains Midday as Dow, S&P Hit New Highs
MT Newswires · 2d ago
Chemomab Therapeutics Files Shelf of Up to About 7.2 Million ADSs on Behalf of Selling Shareholders
MT Newswires · 2d ago
BRIEF-Chemomab Files For Resale Of Up To 7.2 Million ADSs By Selling Shareholders
reuters.com · 3d ago
BRIEF-Chemomab Announces Four New Appointments To Board
reuters.com · 03/29 13:22
Chemomab Announces Four New Appointments to the Board of Directors and Completion of PIPE Financing
TEL-AVIV, Israel, March 29, 2021 /PRNewswire via COMTEX/ -- TEL-AVIV, Israel, March 29, 2021 /PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a...
PR Newswire - PRF · 03/29 13:00
Genesis Prize Co-Founder Stan Polovets Steps Down as Chairman of Anchiano Therapeutics after Company Posts 630% Return in 12 Months
, /PRNewswire/ -- The Genesis Prize Foundation today announced that its co-founder has stepped down as chairman of the board of Anchiano Therapeutics (NASDAQ ANCN), a biopharmaceutical company dedicated to the discovery, development, and commercializatio...
PR Newswire - PRF · 03/22 11:00
SVRA, ZYNE, CANF and CLSK among midday movers
Gainers: SunLink Health Systems (SSY) +219%.Can-Fite BioPharma (CANF) +53%.Savara (SVRA) +37%.Fintech Acquisition (FTCVU) +31%.New Fortress Energy (NFE) +27%.Lizhi (LIZI) +26%.Enzo Biochem (ENZ) +25%.iSun (ISUN) +23%.Anchiano Therapeutics (ANCN) +21%.Optim...
Seekingalpha · 03/16 16:41
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CMMB. Analyze the recent business situations of Chemomab Therapeutics Ltd through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CMMB stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 12
Institutional Holdings: 318.74K
% Owned: 2.98%
Shares Outstanding: 10.70M
TypeInstitutionsShares
Increased
1
3.53K
New
3
6.61K
Decreased
0
0
Sold Out
4
39.53K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.60%
Pharmaceuticals & Medical Research
+0.89%
Key Executives
Chairman/Director
Stephen Squinto
Chief Executive Officer/Chief Scientific Officer/Director
Adi Mor
Chief Financial Officer
Sigal Fattal
Senior Vice President
Ronald Knickerbocker
Vice President
Sean Daly
Vice President - Research & Development
Michal Gilon Ohev-Zion
Other
Aaron Aharon
Other
Joseph Ginossar
Other
David Kerstein
Director
Neil Cohen
Director
Nissim Darvish
Director
Joel Maryles
Director
Alan Moses
Director
Claude Nicaise
Independent Director
Lawrence Howard
No Data
  • All
  • Financials
  • Insiders
More
About CMMB
Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.

Webull offers kinds of Chemomab Therapeutics Ltd - ADR stock information, including NASDAQ:CMMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMMB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CMMB stock methods without spending real money on the virtual paper trading platform.